stride study semaglutide ACC 25: improves PAD patients with T2D Semaglutide cardiovascular outcomes align more

Gastrointestinal side effectsparticularly nausea and diarrheaare the most frequent, affecting 2540% of users in early weeks

Of the entire study population, 41 patients (47.7%) had cardiac outcomes, 12 patients (13.9%) had gastrointestinal outcomes, 22 (25.7%) had neurological outcomes, 7 patients (8.1%) had renal outcomes, 2 patients (2.3%) had gynaecological outcomes, and 2 patients (2.3%) had dermatological outcomes

So, it is preferred to keep a track of Internal Resistance reading displayed on the charger, if your charger supports that

Endothelial dysfunction: mechanisms and contribution to diseases

More serious, though extremely rare, side effects include infection within the joint, which would be marked by severe pain, swelling, and fever, and would require immediate medical attention